Immunosuppression in childhood acute lymphoblastic leukemia after remission induction therapy concerns B not T lymphocytes

✍ Scribed by Luczynski, Wlodzimierz ;Krawczuk-Rybak, Maryna ;Muszynska-Roslan, Katarzyna ;Stasiak-Barmuta, Anna ;Zak, Janusz

• Publisher: John Wiley and Sons
• Year: 2002
• Tongue: English
• Weight: 34 KB
• Volume: 39
• Category: Article
• ISSN: 0098-1532
• DOI: 10.1002/mpo.10061

✦ Synopsis

Concluding, the presented results suggest the need for frequent immunologic monitoring of patients subjected to immunosuppressive treatment; in the case of deficiency (mainly of the humoral system), substitutive therapy should be instituted, like in hypogammaglobulinemia.